McKesson Highlights 2025 Investor Day With New Org Structure, Portfolio Update, And Strategic Focus On Oncology And Biopharma; Reaffirms Growth Priorities And Long-Term Value Creation

Author: Benzinga Newsdesk | September 23, 2025 08:13am

McKesson Corporation (NYSE:MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company's multi-year strategic priorities, growth strategies, and long-term business outlook.

The Investor Day event will showcase how McKesson continues to accelerate long-term growth and deliver sustained value creation:

• Executing strategic priorities: Demonstrating significant progress, focusing on people and culture, strengthening North American Pharmaceutical distribution, modernizing and accelerating the portfolio, and expanding oncology, multispecialty, and biopharma services platforms.
• Advancing portfolio optimization: Providing an update on portfolio developments, including the Medical-Surgical separation.
• Reaffirming growth pillars: Highlighting McKesson's differentiated assets and capabilities across oncology, multispecialty, and biopharma services, positioning the company to lead in high-growth markets and improve patient health outcomes.
• Introducing a new organizational structure: As announced on September 18, 2025, the new structure reflects McKesson's sharpened focus on accelerating growth, enhancing transparency, capital allocation and shareholder value creation.
• Delivering financial updates: Providing a financial overview, updated Fiscal 2026 guidance and a long-term outlook that underscores the company's commitment to shareholder value creation.
• Raising guidance: Increasing and narrowing Fiscal 2026 Adjusted Earnings per Diluted Share guidance range to $38.05 to $38.55 from the previous range of $37.10 to $37.90.

Posted In: MCK